Qubit Pharmaceuticals’ Post

View organization page for Qubit Pharmaceuticals, graphic

7,220 followers

We are proud to announce that our latest research paper, "Polylogarithmic-depth controlled-NOT gates without ancilla qubits," has been published in Nature Communications (Nature Portfolio)! 👏 This work, led by our CSO and cofounder, Jean-Philip Piquemal, and his team, introduces a method for decomposing multi-control NOT gates into native quantum gates, achieving exponentially shorter circuits than previous methods. This breakthrough enhances the efficiency of quantum algorithms, with significant implications for fields such as quantum chemistry, physics, finance, and machine learning. In industries like #drugdiscovery and development, where the demand for computing power is ever-increasing, our advancements in quantum computing offer promising solutions. The frequency and quality of peer-reviewed publications in top-tier journals like Nature Communications highlight the exceptional standards and impact of our research - and we couldn't be prouder of the team. 🌟 Congratulations to Baptiste Claudon, Julien Zylberman, César Feniou, in collaboration with Fabrice Debbasch and Alberto Peruzzo, as well as, of course, Jean-Philip Piquemal. Our ongoing collaboration with Sorbonne Université and Centre national de la recherche scientifique continues to drive our research forward - bringing us yet one step closer to unlocking the power of quantum at scale to design better treatments for particularly complex targets. Read Jean-Philip's Blog for some 'behind the paper' insights: https://lnkd.in/ecmtCSuT Explore the full paper here: https://lnkd.in/e3-nKaj6 #QuantumComputing #DrugDiscovery #QuantumAlgorithms #NatureCommunications #QubitPharmaceuticals #ResearchAndDevelopment

Polylogarithmic-depth controlled-NOT gates without ancilla qubits

Polylogarithmic-depth controlled-NOT gates without ancilla qubits

communities.springernature.com

To view or add a comment, sign in

Explore topics